These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. SOHO State-of-the-Art Updates and Next Questions: A Modern Approach to the Systemic Treatment of Advanced CTCL. Brazel D; Pinter-Brown L Clin Lymphoma Myeloma Leuk; 2023 Jun; 23(6):401-409. PubMed ID: 37061415 [TBL] [Abstract][Full Text] [Related]
25. Heterogeneity of T-cell receptor expression at transformation in mycosis fungoides/Sezary Syndrome (MF/SS). Jothishankar B; Venkataraman G; Goldberg RC; Abdulla F Ann Diagn Pathol; 2019 Dec; 43():151404. PubMed ID: 31629155 [No Abstract] [Full Text] [Related]
26. Lymph node involvement by mycosis fungoides and Sézary syndrome mimicking angioimmunoblastic T-cell lymphoma. LeBlanc RE; Lefterova MI; Suarez CJ; Tavallaee M; Kim YH; Schrijver I; Kim J; Gratzinger D Hum Pathol; 2015 Sep; 46(9):1382-9. PubMed ID: 26193796 [TBL] [Abstract][Full Text] [Related]
27. Management of mycosis fungoides. Part 1. Diagnosis, staging, and prognosis. Smith BD; Wilson LD Oncology (Williston Park); 2003 Sep; 17(9):1281-8. PubMed ID: 14569854 [TBL] [Abstract][Full Text] [Related]
28. Localization of clonal T cells to the epidermis in cutaneous T-cell lymphoma. Fivenson DP; Hanson CA; Nickoloff BJ J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):717-23. PubMed ID: 7929915 [TBL] [Abstract][Full Text] [Related]
29. Histopathology and genetics of cutaneous T-cell lymphoma. Smoller BR; Santucci M; Wood GS; Whittaker SJ Hematol Oncol Clin North Am; 2003 Dec; 17(6):1277-311. PubMed ID: 14710885 [TBL] [Abstract][Full Text] [Related]
30. If small plaque (digitate) parapsoriasis is a cutaneous T-cell lymphoma, even an 'abortive' one, it must be mycosis fungoides! Ackerman AB Arch Dermatol; 1996 May; 132(5):562-6. PubMed ID: 8624154 [No Abstract] [Full Text] [Related]
31. Cutaneous T cell lymphomas: mycosis fungoides, Sezary syndrome and HTLV-I-associated adult T cell leukemia (ATL) in Mali, West Africa: a clinical, pathological and immunovirological study of 14 cases and a review of the African ATL cases. Fouchard N; Mahe A; Huerre M; Fraitag S; Valensi F; Macintyre E; Sanou F; de The G; Gessain A Leukemia; 1998 Apr; 12(4):578-85. PubMed ID: 9557617 [TBL] [Abstract][Full Text] [Related]
32. Prognostic factors and prediction of prognosis by the CTCL Severity Index in mycosis fungoides and Sézary syndrome. Klemke CD; Mansmann U; Poenitz N; Dippel E; Goerdt S Br J Dermatol; 2005 Jul; 153(1):118-24. PubMed ID: 16029336 [TBL] [Abstract][Full Text] [Related]
33. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas. Bosisio FM; Cerroni L Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852 [TBL] [Abstract][Full Text] [Related]
34. Is bone marrow biopsy necessary in patients with mycosis fungoides and Sézary syndrome? A histological and molecular study at diagnosis and during follow-up. Beylot-Barry M; Parrens M; Delaunay M; Thiebault R; Vergier B; DeMascarel A; Dubus P; Beylot C; Merlio JP Br J Dermatol; 2005 Jun; 152(6):1378-9. PubMed ID: 15949023 [No Abstract] [Full Text] [Related]
35. Lymphoma-associated hemophagocytic syndrome (LAHS) in advanced-stage mycosis fungoides/Sézary syndrome cutaneous T-cell lymphoma. Blom A; Beylot-Barry M; D'Incan M; Laroche L J Am Acad Dermatol; 2011 Aug; 65(2):404-410. PubMed ID: 21550694 [TBL] [Abstract][Full Text] [Related]